Trials / Active Not Recruiting
Active Not RecruitingNCT04254731
Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals
The Study of Potential Normalization of Cardiac Rhythm Following Drug Exchange From Chimeric Methadone to Active Methadone
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Effects of switching from racemic methadone to R-methadone on serum methadone concentrations and QTc intervals
Detailed description
Racemic methadone may prolong the QTc interval, which is associated with fatal arrhythmias. In vitro studies have shown that R-methadone has less inhibitory effect than S-methadone on the voltage-gated potassium channel current, and is thus thought to have less effect on the QTc interval. The investigators hypothesized that switching from racemic to R-methadone would reduce the methadone serum concentration and also its effect on the QTc interval.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Same individuals treated with racemic methadone and switched to levomethadone (R-methadone) |
Timeline
- Start date
- 2015-05-07
- Primary completion
- 2018-06-27
- Completion
- 2024-07-30
- First posted
- 2020-02-05
- Last updated
- 2024-04-03
Locations
3 sites across 1 country: Norway
Source: ClinicalTrials.gov record NCT04254731. Inclusion in this directory is not an endorsement.